Fig. 9. Role of PKA in the organization of ER exit sites. (A) Presence of PKA at the ER exit sites. Cells overexpressing CFP-tagged forms of the indicated mutated versions of Sar1p were fixed and processed for immunofluorescence with antibodies to C
. (B) PKA displacement does not affect the distribution of ER exit sites. Cells incubated for 80 hours with siRNA to target either the human or the rodent form of RII
were fixed and processed for immunofluorescence with antibodies to Sec13p. Staining of the centrosome is indicated with arrowheads. Bars, 10 µm.